Mandelia Ashish (CIK 0001782805)

Latest company ownership

MRSN - Mersana Therapeutics, Inc.
Role: VP, Chief Accounting Officer
Shares held
16,667
Last filed at
Jan 17, 2025
Confidence Score
49.7
2025Q4
Confidence Score History
2020Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 15, 2025 Jan 17, 2025 Mersana Therapeutics, Inc. VP, Chief Accounting Officer Sell 37.5 -3,554 -5.82% ✓ $2.1K
Jan 14, 2025 Jan 16, 2025 Mersana Therapeutics, Inc. VP, Chief Accounting Officer Sell 42.5 -1,791 -3.31% ✓ $1.1K
Jan 13, 2025 Jan 15, 2025 Mersana Therapeutics, Inc. VP, Chief Accounting Officer Sell 50.0 -1,007 -2.00% ✓ $664.6
Oct 1, 2024 Oct 7, 2024 Mersana Therapeutics, Inc. VP, Chief Accounting Officer Sell 28.8 -8,216 -14.68% ✓ $16.3K
Jan 13, 2024 Jan 17, 2024 Mersana Therapeutics, Inc. VP, Chief Accounting Officer Sell 23.8 -5,025 -17.72% ✓ $13.6K
Jan 14, 2023 Jan 18, 2023 Mersana Therapeutics, Inc. VP, Controller Sell 46.3 -3,575 -20.79% ✗ $20.5K
Jan 14, 2022 Jan 19, 2022 Mersana Therapeutics, Inc. VP, Controller Sell 46.3 -1,982 -37.03% ✗ $11.7K
Jul 1, 2021 Jul 2, 2021 Mersana Therapeutics, Inc. VP, Controller Sell 13.8 -942 -100.00% ✓ $12.8K
Jan 15, 2021 Jan 20, 2021 Mersana Therapeutics, Inc. VP, Controller Sell 13.8 -834 -100.00% ✓ $17.7K
Jan 4, 2021 Jan 6, 2021 Mersana Therapeutics, Inc. VP, Controller Sell 15.0 -247 -100.00% ✓ $6.6K
Jun 30, 2020 Jul 6, 2020 Mersana Therapeutics, Inc. VP, Controller Sell 53.8 - 0.00% ✓ $59.6K